PMA-104R

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NamePMA-104R
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmedArtis GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmedArtis GmbH
Active IndicationsN/A
Inactive IndicationsSolid tumoursProstatic NeoplasmsPancreatic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A